C12N 2501/34
Calcitonin
Official title: Calcitonin; Calcitonin-gene related peptide [CGRO]; Amylin
C12N2501/34 (Calcitonin) appears on 6 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 11
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Methods and compositions to maintain stem cell quiescence18 Mar 2025US 12,251,404 B2The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions to maintain stem cell quiescence18 Apr 2023US 11,628,188 B2The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions to maintain stem cell quiescence23 Jun 2020US 10,688,136 B2The Board of Trustees of the Leland Stanford Junior University
- Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-3712 Mar 2013US 8,394,767 B2University of Rochester
- Therapeutic method24 Apr 2007US 7,208,469 B2Auckland Uniservices Limited
- Methods and compositions to maintain stem cell quiescence21 Sep 2023US 2023/0293596 A1The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions to maintain stem cell quiescence27 Aug 2020US 2020/0268804 A1The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions to maintain stem cell quiescence23 Nov 2017US 2017/0335287 A1The Board of Trustees of the Leland Stanford Junior University
- Methods of treating cancer using an agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor4 Aug 2011US 2011/0189205 A1University of Rochester
- Fat-Derived Progenitor Cell and Use Thereof25 Dec 2008US 2008/0317720 A1
Most cited
By later US patents
- Methods and compositions to maintain stem cell quiescence5US 10,688,136 B2The Board of Trustees of the Leland Stanford Junior University · 2020
- Therapeutic method2US 6,869,926 B1Auckland Uniservices Limited · 2005
- Therapeutic method2US 7,208,469 B2Auckland Uniservices Limited · 2007
- Methods and compositions to maintain stem cell quiescence1US 11,628,188 B2The Board of Trustees of the Leland Stanford Junior University · 2023